6OTA
 
 | |
6CGX
 | | Backbone cyclised conotoxin Vc1.1 mutant - D11A, E14A | | Descriptor: | Alpha-conotoxin Vc1A | | Authors: | Clark, R.J. | | Deposit date: | 2018-02-21 | | Release date: | 2018-05-23 | | Last modified: | 2024-11-06 | | Method: | SOLUTION NMR | | Cite: | Structure-Activity Studies Reveal the Molecular Basis for GABAB-Receptor Mediated Inhibition of High Voltage-Activated Calcium Channels by alpha-Conotoxin Vc1.1.
ACS Chem. Biol., 13, 2018
|
|
2L1Q
 | |
2AK0
 | | Structure of cyclic conotoxin MII-7 | | Descriptor: | Alpha-conotoxin MII | | Authors: | Clark, R.J, Fischer, H, Dempster, L, Daly, N.L, Rosengren, K.J, Nevin, S.T, Meunier, F.A, Adams, D.J, Craik, D.J. | | Deposit date: | 2005-08-02 | | Release date: | 2005-09-06 | | Last modified: | 2024-10-30 | | Method: | SOLUTION NMR | | Cite: | Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the {alpha}-conotoxin MII.
Proc.Natl.Acad.Sci.USA, 102, 2005
|
|
2AJW
 | | Structure of the cyclic conotoxin MII-6 | | Descriptor: | Alpha-conotoxin MII | | Authors: | Clark, R.J, Fischer, H, Dempster, L, Daly, N.L, Rosengren, K.J, Nevin, S.T, Meunier, F.A, Adams, D.J, Craik, D.J. | | Deposit date: | 2005-08-02 | | Release date: | 2005-09-06 | | Last modified: | 2024-11-13 | | Method: | SOLUTION NMR | | Cite: | Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the {alpha}-conotoxin MII.
Proc.Natl.Acad.Sci.USA, 102, 2005
|
|
2F2I
 | |
2F2J
 | |
2H8S
 | | Solution structure of alpha-conotoxin Vc1.1 | | Descriptor: | Alpha-conotoxin Vc1A | | Authors: | Clark, R.J, Fischer, H, Nevin, S.T, Adams, D.J, Craik, D.J. | | Deposit date: | 2006-06-07 | | Release date: | 2006-06-27 | | Last modified: | 2024-10-09 | | Method: | SOLUTION NMR | | Cite: | The Synthesis, Structural Characterization, and Receptor Specificity of the {alpha}-Conotoxin Vc1.1.
J.Biol.Chem., 281, 2006
|
|
4LMQ
 | | Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12 | | Descriptor: | Stromal cell-derived factor 1, hu30D8 Fab heavy chain, hu30D8 Fab light chain | | Authors: | Zhong, Z, Wang, J, Li, B, Xiang, H, Ultsch, M, Coons, M, Wong, T, Chiang, N.Y, Clark, S, Clark, R, Quintana, L, Gribling, P, Suto, E, Barck, K, Corpuz, R, Yao, J, Takkar, R, Lee, W.P, Damico-Beyer, L.A, Carano, R.D, Adams, C, Kelley, R.F, Wang, W, Ferrara, N. | | Deposit date: | 2013-07-10 | | Release date: | 2013-08-14 | | Last modified: | 2024-11-20 | | Method: | X-RAY DIFFRACTION (2.773 Å) | | Cite: | Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12.
Clin.Cancer Res., 19, 2013
|
|
9BF4
 | | NMR solution structure of Paws Derived Peptide-25 (PDP-25) | | Descriptor: | Paws Derived Peptide-25 | | Authors: | Hajiaghaalipour, F, Wong, W, Payne, C.D, Fisher, M.F, Clark, R.J, Mylne, J.S, Rosengren, K.J. | | Deposit date: | 2024-04-16 | | Release date: | 2025-05-07 | | Method: | SOLUTION NMR | | Cite: | Paws Derived Peptides with two difulfides adopt different structural folds.
To Be Published
|
|
8UWF
 | | NMR structure of the funnel-web spider toxin Hc3a | | Descriptor: | Pi-Hexatoxin-Hc1b_1 | | Authors: | Budusan, E, Payne, C.D, Gonzalez, T.I, Clark, R.J, Rosengren, K.J, Rash, L.D, Cristofori-Armstrong, B. | | Deposit date: | 2023-11-06 | | Release date: | 2024-03-13 | | Last modified: | 2024-11-13 | | Method: | SOLUTION NMR | | Cite: | The funnel-web spider venom derived single knot peptide Hc3a modulates acid-sensing ion channel 1a desensitisation.
Biochem Pharmacol, 228, 2024
|
|
1WN4
 | | NMR Structure of VoNTR | | Descriptor: | VoNTR protein | | Authors: | Dutton, J.L, Renda, R.F, Waine, C, Clark, R.J, Daly, N.L, Jennings, C.V, Anderson, M.A, Craik, D.J. | | Deposit date: | 2004-07-27 | | Release date: | 2004-09-14 | | Last modified: | 2024-05-29 | | Method: | SOLUTION NMR | | Cite: | Conserved structural and sequence elements implicated in the processing of gene-encoded circular proteins
J.Biol.Chem., 279, 2004
|
|
1WN8
 | | NMR Structure of OaNTR | | Descriptor: | Kalata B3/B6 | | Authors: | Dutton, J.L, Renda, R.F, Waine, C, Clark, R.J, Daly, N.L, Jennings, C.V, Anderson, M.A, Craik, D.J. | | Deposit date: | 2004-07-28 | | Release date: | 2004-09-14 | | Last modified: | 2024-05-29 | | Method: | SOLUTION NMR | | Cite: | Conserved structural and sequence elements implicated in the processing of gene-encoded circular proteins
J.Biol.Chem., 279, 2004
|
|
6CFB
 | | Isolation, Characterization, and Synthesis of the Barrettides: Disulfide-Containing Peptides from the Marine Sponge Geodia barretti | | Descriptor: | barrettide A | | Authors: | Rosengren, K.J, Carstens, B.B, Clark, R.J, Goransson, U. | | Deposit date: | 2018-02-14 | | Release date: | 2018-03-21 | | Last modified: | 2024-11-06 | | Method: | SOLUTION NMR | | Cite: | Isolation, Characterization, and Synthesis of the Barrettides: Disulfide-Containing Peptides from the Marine Sponge Geodia barretti.
J. Nat. Prod., 78, 2015
|
|
7L2G
 | |
1Q71
 | | The structure of microcin J25 is a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone | | Descriptor: | microcin J25 | | Authors: | Rosengren, K.J, Clark, R, Daly, N.L, Goransson, U, Jones, A, Craik, D.J. | | Deposit date: | 2003-08-14 | | Release date: | 2003-12-16 | | Last modified: | 2024-11-20 | | Method: | SOLUTION NMR | | Cite: | Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone.
J.Am.Chem.Soc., 125, 2003
|
|
2M2Q
 | | Solution structure of MCh-1: A novel inhibitor cystine knot peptide from Momordica charantia | | Descriptor: | Inhibitor cystine knot peptide MCh-1 | | Authors: | He, W, Chan, L, Clark, R.J, Tang, J, Zeng, G, Franco, O.L, Cantacessi, C, Craik, D.J, Daly, N.L, Tan, N. | | Deposit date: | 2013-01-01 | | Release date: | 2013-11-06 | | Last modified: | 2024-11-06 | | Method: | SOLUTION NMR | | Cite: | Novel Inhibitor Cystine Knot Peptides from Momordica charantia.
Plos One, 8, 2013
|
|
3QRJ
 | | The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036 | | Descriptor: | 4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide, Tyrosine-protein kinase ABL1 | | Authors: | Chan, W.W, Wise, S.C, Kaufman, M.D, Ahn, Y.M, Ensinger, C.L, Haack, T, Hood, M.M, Jones, J, Lord, J.W, Lu, W.P, Miller, D, Patt, W.C, Smith, B.D, Petillo, P.A, Rutkoski, T.J, Telikepalli, H, Vogeti, L, Yao, T, Chun, L, Clark, R, Evangelista, P, Gavrilescu, L.C, Lazarides, K, Zaleskas, V.M, Stewart, L.J, Van Etten, R.A, Flynn, D.L. | | Deposit date: | 2011-02-18 | | Release date: | 2011-06-01 | | Last modified: | 2024-04-03 | | Method: | X-RAY DIFFRACTION (1.82 Å) | | Cite: | Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036.
Cancer Cell, 19, 2011
|
|
2M2R
 | | Solution structure of MCh-2: A novel inhibitor cystine knot peptide from Momordica charantia | | Descriptor: | Inhibitor cystine knot peptide MCh-2 | | Authors: | He, W, Chan, L, Clark, R.J, Tang, J, Zeng, G, Franco, O.L, Cantacessi, C, Craik, D.J, Daly, N.L, Tan, N. | | Deposit date: | 2013-01-01 | | Release date: | 2013-11-06 | | Last modified: | 2024-11-27 | | Method: | SOLUTION NMR | | Cite: | Novel Inhibitor Cystine Knot Peptides from Momordica charantia.
Plos One, 8, 2013
|
|
3QRK
 | | The crystal structure of human abl1 kinase domain in complex with DP-987 | | Descriptor: | (3S)-6-(3-tert-butyl-5-{[(2,3-dichlorophenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, Tyrosine-protein kinase ABL1 | | Authors: | Chan, W.W, Wise, S.C, Kaufman, M.D, Ahn, Y.M, Ensinger, C.L, Haack, T, Hood, M.M, Jones, J, Lord, J.W, Lu, W.P, Miller, D, Patt, W.C, Smith, B.D, Petillo, P.A, Rutkoski, T.J, Telikepalli, H, Vogeti, L, Yao, T, Chun, L, Clark, R, Evangelista, P, Gavrilescu, L.C, Lazarides, K, Zaleskas, V.M, Stewart, L.J, Van Etten, R.A, Flynn, D.L. | | Deposit date: | 2011-02-18 | | Release date: | 2011-06-01 | | Last modified: | 2024-04-03 | | Method: | X-RAY DIFFRACTION (2.3 Å) | | Cite: | Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036.
Cancer Cell, 19, 2011
|
|
2MSO
 | | Solution study of cGm9a | | Descriptor: | Conotoxin Gm9.1 | | Authors: | Akcan, M, Clark, R.J, Daly, N.L, Conibear, A.C, de Faoite, A.C, Heghinian, M.C, Adams, D.J, Mari, F, Craik, D.J. | | Deposit date: | 2014-08-05 | | Release date: | 2015-07-22 | | Last modified: | 2024-11-06 | | Method: | SOLUTION NMR | | Cite: | Transforming conotoxins into cyclotides: Backbone cyclization of P-superfamily conotoxins.
Biopolymers, 104, 2015
|
|
2MSQ
 | | Solution study of cBru9a | | Descriptor: | Conotoxin cBru9a | | Authors: | Akcan, M, Clark, R.J, Daly, N.L, Conibear, A.C, de Faoite, A.C, Heghinian, M.C, Adams, D.J, Mari, F, Craik, D.J. | | Deposit date: | 2014-08-05 | | Release date: | 2015-07-22 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Transforming conotoxins into cyclotides: Backbone cyclization of P-superfamily conotoxins.
Biopolymers, 104, 2015
|
|
2NS3
 | | Solution structure of ribbon BuIA | | Descriptor: | Alpha-conotoxin BuIA | | Authors: | Jin, A.H, Brandstaetter, H, Nevin, S.T, Tan, C.C, Clark, R.J, Adams, D.J, Alewood, P.F, Craik, D.J, Daly, N.L. | | Deposit date: | 2006-11-03 | | Release date: | 2007-09-25 | | Last modified: | 2024-10-16 | | Method: | SOLUTION NMR | | Cite: | Structure of alpha-conotoxin BuIA: influences of disulfide connectivity on structural dynamics
Bmc Struct.Biol., 7, 2007
|
|
3QRI
 | | The crystal structure of human abl1 kinase domain in complex with DCC-2036 | | Descriptor: | 4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide, SODIUM ION, Tyrosine-protein kinase ABL1 | | Authors: | Chan, W.W, Wise, S.C, Kaufman, M.D, Ahn, Y.M, Ensinger, C.L, Haack, T, Hood, M.M, Jones, J, Lord, J.W, Lu, W.P, Miller, D, Patt, W.C, Smith, B.D, Petillo, P.A, Rutkoski, T.J, Telikepalli, H, Vogeti, L, Yao, T, Chun, L, Clark, R, Evangelista, P, Gavrilescu, L.C, Lazarides, K, Zaleskas, V.M, Stewart, L.J, Van Etten, R.A, Flynn, D.L. | | Deposit date: | 2011-02-18 | | Release date: | 2011-06-01 | | Last modified: | 2024-04-03 | | Method: | X-RAY DIFFRACTION (2.1 Å) | | Cite: | Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036.
Cancer Cell, 19, 2011
|
|
2B38
 | | Solution structure of kalata B8 | | Descriptor: | kalata B8 | | Authors: | Daly, N.L, Clark, R.J, Plan, M.R, Craik, D.J. | | Deposit date: | 2005-09-19 | | Release date: | 2006-01-31 | | Last modified: | 2024-10-30 | | Method: | SOLUTION NMR | | Cite: | Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif
Biochem.J., 393, 2006
|
|
